Announcements
Vacancy Notification Recruitment of Administrative & Technical Cadre Post for Project Research Scientist-II ( Medical) Post for Project Research Scientist-I (Non Medical) List of selected candidates for Ph.D. (Medical Research), August 2025 batch, Under ICMR- AcSIR List of Shortlisted Candidates for YP-II (Scientifc) List of Shortlisted Candidates for YP-II (F&A) Equipment Tenders 26 - 2025 on GeM portal Tender Documents for Laboratory Chemicals and Consumables
NIIH | PID Research

Centre of Excellence for Diagnosis Of Primary Immunodeficiency Disorders (PID)

Vision Image
  • Established state-of-the-art facilities for evaluation of suspected cases of Inborn Errors of Immunity (IEIs).
  • Evaluated a total of 11,510 suspected Primary Immunodeficiency (PID) cases, with confirmed diagnosis in 909 cases.
  • Based on screening results, specialized assays and genetic confirmation using Sanger sequencing or next-generation sequencing (NGS) were performed.
  • Established normal reference ranges for rare lymphocyte subsets in the Indian population.
  • Set up facilities for prenatal diagnosis (PND) using cordocentesis, amniotic fluid, and CVS samples via flow cytometry and molecular techniques.
  • PND offered in 56 families (64 pregnancies): 32 cases with phenotypic diagnosis via cordocentesis and 32 via molecular analysis.
  • Prepared standard operating procedures (SOPs) for common diagnostic tests for PIDs.
  • Drafted a policy brief to the Government of India recommending free IVIg therapy for patients with hypogammaglobulinemia.
  • Organized annual CME-cum-flow cytometry training workshops since 2011 to create awareness and build diagnostic capacity across India.
  • Conducted 13 training programmes, training over 800 participants nationwide, along with numerous CMEs and PID awareness programmes in various centers.

Established Diagnostic facilitates for IEIs Lymphocyte subset analysis:

I. T Cells and Their Subsets

  • T helper (CD4+)/ T cytotoxic (CD8+)
  • Naïve (CCR7+/CD62L+/CD27+/CD45RA+)
  • Memory (CCR7+/CD62L+/CD27+/CD45RA-)
  • Effector (CCR7-/CD62L-/CD27-/CD45RA-)
  • TEMRA (CCR7+/CD62L+/CD27+/CD45RA-)
  • TsCM (CCR7+CD45RA+CD28+CD95+)
  • CD8+CD28- T cell
  • Senescent (CD57+CD28-)
  • Exhausted (PD1+/Tim3+)
  • T follicular helper (CXCR5+CD45RA-PD1+)
  • Th1/ Tc1-like (CXCR3+CCR4-)
  • Th2/ Tc2-like (CXCR3-CCR4+CCR6-)
  • Th17/ Tc17-like (CCR4+CCR6+CCR10-)
  • Th9 (CCR4-CCR6+)
  • Th22 (CCR4+CCR10+CCR6+)
  • Recent thymic emigrants (CD31+CD62L+CD45RA+)
  • αβ+ T cells (GD-)
  • γδ+ T cells (GD+)

II. Regulatory T Cells and Their Subsets

  • Treg (CD4/CD8) (CD25++CD127-/low)
  • Memory Treg (CD95+CCR4+CD45RAlowHLADR+)
  • Naïve Treg (CD45RA+CCR4-/lowCD95-)
  • V beta repertoire analysis

III. B Cells and Their Subsets

  • Naïve (CD27-IgD+)
  • Memory (CD27+IgD+)
  • Class-switched memory (CD27-IgM-IgD-)
  • Germinal centre (CD27+IgD-)
  • Marginal zone (CD27+IgD+IgM+)
  • IgM-only memory (CD27+IgD-IgM+)
  • CD21 low (CD21-/CD38-)
  • Plasmablast (CD27+CD24+CD38+)
  • Activated B cell (CD95+CD38-)
  • B regulatory (CD24++CD38++)
  • Transitional 1 (CD27-IgD+ CD24+ CD10+ CD38+)
  • Transitional 2 (CD27-IgD+CD10-CD38+)
  • Transitional 3 (CD27-IgD+CD10-CD38-)

IV. Double Negative T (DNT) Cells and Their Subsets

  • B220+ : Proliferative DNTs
  • CD27+CD28+ : Naïve DNTs
  • CD45RA-CD27- : Effector DNTs
  • CD57+KLRG1- : Senescent DNTs
Vision Image

Established Diagnostic facilitates for IEIs Lymphocyte subset analysis:

Surface Protein Expression for the Diagnosis of Specific IEIs

  • Btk: X-linked agammaglobulinemia
  • CD127: IL-7 receptor α deficiency
  • CD132: X-linked SCID
  • CD18/CD11a/CD11b/CD11c: LAD-I
  • CD40: AR Hyper IgM syndrome
  • CD40L: X-linked Hyper IgM syndrome
  • DOCK8: DOCK8 deficiency
  • WASp: Wiskott-Aldrich Syndrome
  • p47, p22, p67: Chronic Granulomatous Disease
  • IL12Rb1: MSMD
  • IFNgR1: MSMD
  • CTLA4: CTLA4 haploinsufficiency
  • LRBA: LRBA deficiency
  • Perforin: FHL2
  • XIAP: XLP2
  • FoxP3: IPEX syndrome
  • NKg2D expression: XMEN syndrome

Functional Assays

  • pSTAT1, pSTAT3, pSTAT4, pSTAT5
  • Granule release assay
  • NBT/DHR/FMLP
  • Apoptosis assay
  • CD154 expression
  • CD62L shedding
  • RBC ADA levels
  • T cell proliferation by PHA, anti-CD3, and CD28

Other Specialized Tests

  • TREC
  • T cell Vβ repertoire
  • Immunoglobulin levels (IgG, IgA, IgM, IgE)
  • IgG subclass analysis (IgG2, IgG4)
  • Specific antibody responses (anti-tetanus, anti-typhoid)
  • Complement system evaluation (CH50, AH50)
Vision Image

What's New

View All